metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology
Información de la revista
Número
Vol. 28. Núm. 5.
(septiembre - octubre 2023)
Editorial board
Ann Hepatol. 2023;28:101146
Acceso a texto completo
Editorial
Gut dysbiosis in alcoholic liver disease: Wonderful dilemma?
Ludovico Abenavoli, Emidio Scarpellini
Ann Hepatol. 2023;28:101123
Acceso a texto completo
Opinions
Nonalcoholic fatty liver disease: A risk factor for chronic kidney disease
Kellyane Dias Carvalho, Carla Daltro, Raquel Rocha, Helma P. Cotrim
Ann Hepatol. 2023;28:101122
Acceso a texto completo
Concise reviews
Anti-gp210-positive primary biliary cholangitis: The dilemma of clinical treatment and emerging mechanisms
Xiaoyi Wang, Zhen Yang, Ying Ran, Long Li, Bangmao Wang, Lu Zhou
Ann Hepatol. 2023;28:101121
Acceso a texto completo
Original articles
Terlipressin in combination with albumin as a therapy for hepatorenal syndrome in patients aged 65 years or older
Muhammad A. Mujtaba, Ann Kathleen Gamilla-Crudo, Shehzad N. Merwat, Syed A. Hussain, Michael Kueht, Aftab Karim, Muhammad W. Khattak, Peggy J. Rooney, Khurram Jamil
Ann Hepatol. 2023;28:101126
Acceso a texto completo
Examining genetic associations with hepatic steatosis in Mexican-origin adults
Mario Jesus Trejo, Kristin E. Morrill, Yann C. Klimentidis, David O. Garcia
Ann Hepatol. 2023;28:101120
Acceso a texto completo
Improved bone and renal safety in younger tenofovir disoproxil fumarate experienced chronic hepatitis B patients after switching to tenofovir alafenamide or entecavir
Fa- Da Wang, Jing Zhou, Lan-Qing Li, Yu-Jing Li, Meng-Lan Wang, Ya-Chao Tao, Dong-Mei Zhang, Yong-Hong Wang, En-Qiang Chen
Ann Hepatol. 2023;28:101119
Acceso a texto completo
IL-18 discriminates highly frequent hepatitis E virus positive from negative blood donors in Mexico
Edgar D. Copado-Villagrana, Antonio Pizuorno, Adrián García-Suárez, Julio C. Abarca, Gisela DuPont, Socorro Jaramillo-Bueno, Nora A. Fierro
Ann Hepatol. 2023;28:101117
Acceso a texto completo
CSNK2A2 promotes hepatocellular carcinoma progression through activation of NF-κB pathway
Shuang Yang, Li Rong Peng, Ai Qing Yu, Jiang Li
Ann Hepatol. 2023;28:101118
Acceso a texto completo
Circular RNA hsa_circ_0098181 inhibits metastasis in hepatocellular carcinoma by activating the Hippo signaling pathway via interaction with eEF2
Ping Gao, Yuan Yang, Xiaowei Li, Qi Zhao, Yujin Liu, Chunnan Dong, Yanan Zhang, Dianwu Liu
Ann Hepatol. 2023;28:101124
Acceso a texto completo
Racial, ethnic, and socioeconomic disparities impact post-liver transplant survival in patients with hepatocellular carcinoma
Dora C. Huang, Rosa L. Yu, Saleh Alqahtani, Hani Tamim, Behnam Saberi, Alan Bonder
Ann Hepatol. 2023;28:101127
Acceso a texto completo
Effect of acute on chronic liver failure over post-transplant survival
Carlos Benítez, Jorge Arnold, Verónica Cambindo, Fernanda Schoenfeldt, Alejandra Cancino, Samuel Ibáñez, Catalina Grandy, Paola Hunfan, ... Vicente Pizarro
Ann Hepatol. 2023;28:101128
Acceso a texto completo
Association between klotho and non-alcoholic fatty liver disease and liver fibrosis based on the NHANES 2007–2016
Zhenfei Chi, Yun Teng, Yuting Liu, Lu Gao, Junhan Yang, Zhe Zhang
Ann Hepatol. 2023;28:101125
Acceso a texto completo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos